Screener
Bioventus BVS Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Number of options | Weighted-average exercise price | Weighted-average remaining contractual term | Aggregate intrinsic value(1) |
|---|---|---|---|---|
| Outstanding at December 31, 2025 | 4,664 | $7.77 | 7.06 | $7,780 |
| Granted | 1,047 | 8.60 | ||
| Exercised | (55) | 4.03 | ||
| Forfeited or canceled | (67) | 9.26 | ||
| Outstanding at June 27, 2026 | 5,589 | $7.94 | 7.12 | $14,750 |
| Exercisable and vested at June 27, 2026 | 3,079 | $8.56 | 5.90 | $8,130 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, exercisable, number?
- Bioventus (BVS) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, exercisable, number of 3.1M in Q2 2026.
- How has Bioventus's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, exercisable, number changed year-over-year?
- Bioventus's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, exercisable, number increased by 34.3% year-over-year, from 2.3M to 3.1M.
- What does share-based compensation arrangement by share-based payment award, options, vested and expected to vest, exercisable, number mean?
- Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number as reported by Bioventus Inc. Class A Common Stock.
Ask your AI about Bioventus's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, exercisable, number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude